We found that TNFα treatment induced CCL2, CCL13, and IL8 mRNA expression in most fatal asthma- and non-asthma-derived ASM samples, but TNFα treatment did not induce CXCL12 [Fig 2]. The gene discussed is CCL13; the disease is asthma.